Considering the fact that efficient treatment responses depend on the interaction of the therapeutic agents with cancer cells and TME, focusing on the ability of MSCs to produce and release AMPs and the anticancer role of AMPs in TME could shed light on new anticancer mechanisms of MSCs (Wheeler et al., 2021). The gene discussed is ADSL; the disease is cancer.